Therapeutic Asset Ratings

722 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Monomethyl Fumarate Acute Undifferentiated Leukemia	Masonic Cancer Center, University of Minnesota	P2	BB (68)
Romidepsin Recurrent Adult Lymphoblastic Lymphoma	Masonic Cancer Center, University of Minnesota	P2	BB (68)
Busulphan Recurrent Adult Lymphoblastic Lymphoma	Masonic Cancer Center, University of Minnesota	P2	BB (67)
Busulphan Fucosidosis	Masonic Cancer Center, University of Minnesota	P2/3	BB (67)
Busulphan Globoid Cell Leukodystrophy	Masonic Cancer Center, University of Minnesota	P2/3	BB (67)
Busulphan Metachromatic Leukodystrophy	Masonic Cancer Center, University of Minnesota	P2/3	BB (67)
Fludarabine Osteopetrosis	Masonic Cancer Center, University of Minnesota	P2/3	BB (67)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Osteopetrosis	Masonic Cancer Center, University of Minnesota	P2/3	BB (67)
Cyclophosphamide Central Nervous System Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (66)
Evomela Juvenile Myelomonocytic Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (66)
Evomela Non-Hodgkin Lymphoma	Masonic Cancer Center, University of Minnesota	P3	BB (66)
Fludarabine Anemia	Masonic Cancer Center, University of Minnesota	P3	BB (66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Juvenile Myelomonocytic Leukemia (JMML)	Masonic Cancer Center, University of Minnesota	P3	BB (66)
Monomethyl Fumarate Acute Biphenotypic Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (66)
Monomethyl Fumarate Natural Killer Cell Malignancies	Masonic Cancer Center, University of Minnesota	P3	BB (66)
Monomethyl Fumarate Recurrent Chronic Lymphocytic Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (66)
Rapamycin Chronic Myeloproliferative Disorders	Masonic Cancer Center, University of Minnesota	P3	BB (66)
Evomela Anemia, Aplastic	Masonic Cancer Center, University of Minnesota	P2	BB (66)
Evomela Non-Hodgkin's Lymphoma	Masonic Cancer Center, University of Minnesota	P2	BB (66)
Romidepsin Juvenile Myelomonocytic Leukemia	Masonic Cancer Center, University of Minnesota	P2	BB (66)
Anti-Thymoglobulin, Rabbit Recurrent Adult Lymphoblastic Lymphoma	Masonic Cancer Center, University of Minnesota	P4	BB (65)
Fludarabine Burkitt Lymphoma	Masonic Cancer Center, University of Minnesota	P2	BB (65)
Fludarabine Fucosidosis	Masonic Cancer Center, University of Minnesota	P2	BB (65)
Fludarabine Hurler Syndrome	Masonic Cancer Center, University of Minnesota	P2	BB (65)
Fludarabine Plasma Cell Leukemia	Masonic Cancer Center, University of Minnesota	P2	BB (65)

Showing 26 to 50 of 722 assets

PreviousPage 2 of 29Next